<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: The Next Big Thing in Health Care: How to Profit From Immunotherapy &amp; Regenerative Medicine</title>
	<atom:link href="http://www.investmentu.com/IUEL/2009/October/the-next-big-thing-in-health-care.html/feed" rel="self" type="application/rss+xml" />
	<link>http://www.investmentu.com/IUEL/2009/October/the-next-big-thing-in-health-care.html</link>
	<description>Investment Advice and Investment Research with a Contrarian Point of View</description>
	<lastBuildDate>Fri, 19 Mar 2010 19:55:11 -0500</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.3</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Chet Billingsley, CEO - MNTR</title>
		<link>http://www.investmentu.com/IUEL/2009/October/the-next-big-thing-in-health-care.html#comment-27748</link>
		<dc:creator>Chet Billingsley, CEO - MNTR</dc:creator>
		<pubDate>Fri, 23 Oct 2009 08:54:40 +0000</pubDate>
		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/October/the-next-big-thing-in-health-care.html#comment-27748</guid>
		<description>Mark  --  Your call on Cancer Immunotherapy is indeed right on the money.  You also may find the Cancer Immunotherapy Index of ten leading immunotherapy companies of particular interest. It is published at our web site www.MentorCapital.com and is up 80% this quarter.  Mentor Capital, (MNTR)likes - and is the largest shareholder in -- Quantum Immunologics, a private company.  Quantum has patents and licenses to attack the OFA protein that is expressed on breast (in Phase I/II Trials) and 500 other cancers trested. Potential for the broader market for the MNTR investee is 2x -10x of Dendreon (DNDN).  Best in good health.</description>
		<content:encoded><![CDATA[<p>Mark  &#8212;  Your call on Cancer Immunotherapy is indeed right on the money.  You also may find the Cancer Immunotherapy Index of ten leading immunotherapy companies of particular interest. It is published at our web site <a href="http://www.MentorCapital.com" rel="nofollow">http://www.MentorCapital.com</a> and is up 80% this quarter.  Mentor Capital, (MNTR)likes &#8211; and is the largest shareholder in &#8212; Quantum Immunologics, a private company.  Quantum has patents and licenses to attack the OFA protein that is expressed on breast (in Phase I/II Trials) and 500 other cancers trested. Potential for the broader market for the MNTR investee is 2x -10x of Dendreon (DNDN).  Best in good health.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Phil Becker</title>
		<link>http://www.investmentu.com/IUEL/2009/October/the-next-big-thing-in-health-care.html#comment-26769</link>
		<dc:creator>Phil Becker</dc:creator>
		<pubDate>Tue, 13 Oct 2009 04:06:19 +0000</pubDate>
		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/October/the-next-big-thing-in-health-care.html#comment-26769</guid>
		<description>As a health care expert, I would assume you have read on the modern healing power of the leeches about which you have jested. Leech therapy actually aids in healing in some cases by enabling enhanced blood flow to tissues.</description>
		<content:encoded><![CDATA[<p>As a health care expert, I would assume you have read on the modern healing power of the leeches about which you have jested. Leech therapy actually aids in healing in some cases by enabling enhanced blood flow to tissues.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Proinvests.com &#187; Blog Archive &#187; The Next Big Thing in Health Care: How to Profit From Immunotherapy &#38; Regenerative Medicine</title>
		<link>http://www.investmentu.com/IUEL/2009/October/the-next-big-thing-in-health-care.html#comment-26288</link>
		<dc:creator>Proinvests.com &#187; Blog Archive &#187; The Next Big Thing in Health Care: How to Profit From Immunotherapy &#38; Regenerative Medicine</dc:creator>
		<pubDate>Thu, 08 Oct 2009 12:11:35 +0000</pubDate>
		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/October/the-next-big-thing-in-health-care.html#comment-26288</guid>
		<description>[...] The Next Big Thing in Health Care: How to Profit From Immunotherapy &amp; Regenerative Medicine [...]</description>
		<content:encoded><![CDATA[<p>[...] The Next Big Thing in Health Care: How to Profit From Immunotherapy &amp; Regenerative Medicine [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Annabelle</title>
		<link>http://www.investmentu.com/IUEL/2009/October/the-next-big-thing-in-health-care.html#comment-26174</link>
		<dc:creator>Annabelle</dc:creator>
		<pubDate>Wed, 07 Oct 2009 20:34:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/October/the-next-big-thing-in-health-care.html#comment-26174</guid>
		<description>The other medical practice which needs to be outdated is the breast mammogram.  The inventor of this machine is definitely a male and does not subject himself to this test.  Imagine a delicate part of your body to be compressed really hard several times in different ways.  Then, they would say that the machine is not very accurate.  It cannot detect problems/cancer at an early stage.  When they found something, you have to subject yourself to the same ordeal again, just to be sure.  What they do not know is this might even be causing the problem.  I wish they would find a better and humane alternative to this test.</description>
		<content:encoded><![CDATA[<p>The other medical practice which needs to be outdated is the breast mammogram.  The inventor of this machine is definitely a male and does not subject himself to this test.  Imagine a delicate part of your body to be compressed really hard several times in different ways.  Then, they would say that the machine is not very accurate.  It cannot detect problems/cancer at an early stage.  When they found something, you have to subject yourself to the same ordeal again, just to be sure.  What they do not know is this might even be causing the problem.  I wish they would find a better and humane alternative to this test.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
